MedTrace Logo

Uterus Transplantation From Live Donor

NCT01844362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-06-24

No results posted yet for this study

Summary

Uterus transplantation, as a possible future treatment for uterine factor infertility, has been developed in animal species during the last decade.

The study protocol includes transplantation of the uterus from a live donor (mother, relative, friend) into women with absolute uterine factor infertility (lack of uterus from birth or due to life saving hysterectomy).The recipient will be treated by standard immunosuppression and transfer of embryos (acquired by IVF before surgery) will be attempted when at least 12 months have passed from transplantation. Approval for a case series including up to 10 patients has been acquired.

Conditions

  • Primary Uterine Infertility

Interventions

PROCEDURE

uterine transplantation

Transplantation of the uterus from live donor and IVF treatment.

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Mats Brännström, MD, PhD · Göteborg University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2018-04-30
Completion
2021-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01844362 on ClinicalTrials.gov